Back to Top

BioDrugs (BioDrugs)

Publisher :

Springer Nature

  • Pharmacology
  • Medicine
  • Biochemistry
  • +2

e-ISSN :

1179-190X

Issue Frequency :

Monthly

Impact Factor :

6.8

p-ISSN :

1173-8804

Est. Year :

1997

Mobile :

6494770700

Country :

New Zealand

Language:

English, Toxicology, Pharmaceutics

APC :

YES

Email :

customerservice@springernature.com

Journal Descriptions

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. The Journal includes: - Definitive reviews on topics relating to the development and use of biotechnology in healthcare and the management of disease. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Original research articles on the clinical development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products. - Leading/Current Opinion articles providing an overview of contentious or emerging issues and key regulatory and ethical issues. - Adis Drug Evaluations reviewing the properties and place in therapy of biotechnology-based drugs. - Adis Biosimilar Briefs summarizing key characteristics and clinical use of biosimilar drugs.


BioDrugs (BioDrugs) is :

International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Medicine, Biochemistry, Molecular Biology, Biotechnology , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 1173-8804, E-ISSN - 1179-190X, Established in - 1997, Impact Factor - 6.8

Not Provide Crossref DOI

Indexed in Scopus, WoS, PubMed, UGC CARE

Not indexed in DOAJ

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile